In the dynamic world of biopharmaceutical innovation, Ivan Kairatov stands out as an expert, particularly in the area of immunotherapy. With substantial experience in research and development, Ivan has been at the forefront of exploring the molecular intricacies of CAR-T cell therapy. This
Can everyday choices like consuming plant-based foods really influence the effectiveness of cancer treatments? Recent studies have unveiled a surprising link between diet, gut bacteria, and cancer treatment outcomes, especially their impact on PI3K inhibitors used to treat solid tumors. These
Hypoxia, often associated with adverse environmental conditions, has recently emerged as a significant player in the progression of colon cancer. Once considered mainly a problem in cancer treatment due to its potential to inhibit tumor growth by starving the cancer cells of oxygen, new insights
Ivan Kairatov is a renowned expert in biopharma, with a strong track record in research and development, particularly in technological innovations that drive pharmaceutical advancements. With his deep understanding of these domains, Ivan offers insights into groundbreaking studies and developments,
Can a newly discovered genetic syndrome completely reshape how cancer is treated? The emergence of DIAL syndrome, which impairs DNA repair mechanisms and elevates cancer risk, presents that possibility, stirring curiosity among researchers and medical professionals. The revelation raises an
In today's interview, we have the pleasure of speaking with Ivan Kairatov, a biopharma expert renowned for his expertise in technology and innovation within the industry. With extensive experience in research and development, Ivan provides invaluable insights into the current challenges and
